Vanguard Global Advisers’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Vanguard Global Advisers's SION Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Sionna Therapeutics (SION) stake by 26% in Q3 2026, selling an estimated $46.4K and leaving 5,831 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3231.
Vanguard Global Advisers first reported a position in SION in Q1 2026 and has held it in 3 quarters since. The position peaked at $449K in Q1 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Vanguard Global Advisers held 5,831 shares of Sionna Therapeutics worth $30.7K as of Q3 2026.
- Vanguard Global Advisers sold 2,021 Sionna Therapeutics shares in Q3 2026, an estimated $46.4K.
- Sionna Therapeutics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3231 holding.
- Vanguard Global Advisers first reported a position in Sionna Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Sionna Therapeutics position peaked at $449K in Q1 2026.
- 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.